O2L-001

N/A

Report date: 2025/01/26 17:24:41
NME

Base Information

Drug NameO2L-001
Drug Alias Nameoptimized tissue plasminogen activator(Op2lysis/University of Caen/INSERM)O2L-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlasminogen activators
TargetsPlasminogen
Therapy Area/IndicationsCerebral Hemorrhage
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEuropeFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOp2Lysis SAS
China Registration ClassN/A

Develop Information

Active CompaniesInstitut National De La Sante Et De La Recherche MedicaleUniversite de Caen Basse-NormandieOp2Lysis SAS
Inactive CompaniesN/A
Active IndicationsCerebral Hemorrhage
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A